Dr. Kobe Reynders, Radiotherapie-Oncologie (Private limited company)
Dr. Kobe Reynders, Radiotherapie-Oncologie is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 1007.472.781. It was founded on 22-03-2024. Its registered office is in Rotselaar. Its main activity is: Human health activities. Its annual accounts for 2025 report equity of € 201 737 and a profit of € 135 860. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 2 financial years.
Information last updated on 07-10-2026.
Company information
Key figures of Dr. Kobe Reynders, Radiotherapie-Oncologie
| 2025 | 2024 | |
|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 135 860+110 % | € 64 543 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 201 737+202 % | € 66 710 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 246 938+183 % | € 87 388 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 178 567+118 % | € 82 020 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Rotselaar.
| Company | Town |
|---|---|
| DOKTER GUIDO VYNCKE | 3110 Rotselaar |
| FYSIOKON | 3110 Rotselaar |
| Kine Prakticum Materne | 3110 Rotselaar |
| BorgInsole | 3110 Rotselaar |
| MEDENZO | 3110 Rotselaar |
| Vaerdael | 3110 Rotselaar |
| ORTHODONTIEPRAKTIJK KATLEEN SWINNEN | 3110 Rotselaar |
| TANDARTS J. DE CALUWE | 3110 Rotselaar |
Frequently asked questions
Is Dr. Kobe Reynders, Radiotherapie-Oncologie still active? Yes. The Crossroads Bank for Enterprises lists Dr. Kobe Reynders, Radiotherapie-Oncologie as active.
What is the VAT number of Dr. Kobe Reynders, Radiotherapie-Oncologie? Dr. Kobe Reynders, Radiotherapie-Oncologie is not registered for VAT. Its enterprise number is 1007.472.781.
When was Dr. Kobe Reynders, Radiotherapie-Oncologie founded? Dr. Kobe Reynders, Radiotherapie-Oncologie was founded on 22-03-2024.
What is the address of Dr. Kobe Reynders, Radiotherapie-Oncologie? The current registered office of Dr. Kobe Reynders, Radiotherapie-Oncologie is Beukenlaan 70, 3110 Rotselaar.
When did Dr. Kobe Reynders, Radiotherapie-Oncologie last file annual accounts? The latest annual accounts of Dr. Kobe Reynders, Radiotherapie-Oncologie were filed on 29-05-2026.
Does Dr. Kobe Reynders, Radiotherapie-Oncologie file its annual accounts on time? Yes. Dr. Kobe Reynders, Radiotherapie-Oncologie filed its annual accounts within the legal deadline for each of its last 2 financial years.
Is Dr. Kobe Reynders, Radiotherapie-Oncologie financially healthy? Addrly gives Dr. Kobe Reynders, Radiotherapie-Oncologie a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Dr. Kobe Reynders, Radiotherapie-Oncologie profitable? The annual accounts of Dr. Kobe Reynders, Radiotherapie-Oncologie for 2025 show a profit of € 135 860.
What is the equity of Dr. Kobe Reynders, Radiotherapie-Oncologie? The equity of Dr. Kobe Reynders, Radiotherapie-Oncologie was € 201 737 at the close of the 2025 financial year.
Who are the directors of Dr. Kobe Reynders, Radiotherapie-Oncologie? The annual accounts of Dr. Kobe Reynders, Radiotherapie-Oncologie record 1 mandate. The name, role and dates are visible with a free account.
Can Dr. Kobe Reynders, Radiotherapie-Oncologie receive Peppol e-invoices? Yes. Dr. Kobe Reynders, Radiotherapie-Oncologie is registered on the Peppol network and can receive structured electronic invoices.
What does Dr. Kobe Reynders, Radiotherapie-Oncologie do? The main activity of Dr. Kobe Reynders, Radiotherapie-Oncologie is: Human health activities.